Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus - Wikidata - awgldk - TriplyDB

Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus

Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus

http://www.wikidata.org/entity/Q58762088

about

Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus

http://www.wikidata.org/entity/Q58762088

description

article publié dans la revue scientifique PLoS ONE

@fr

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in PLoS ONE

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Effects of pharmacist interven ...... esistant Staphylococcus aureus

@en

Effects of pharmacist interven ...... esistant Staphylococcus aureus

@nl

type

label

Effects of pharmacist interven ...... esistant Staphylococcus aureus

@en

Effects of pharmacist interven ...... esistant Staphylococcus aureus

@nl

prefLabel

Effects of pharmacist interven ...... esistant Staphylococcus aureus

@en

Effects of pharmacist interven ...... esistant Staphylococcus aureus

@nl

P1433

Q58762088-3D92A302-F855-40AA-9D68-718E8E423F1C

P1476

Q58762088-2CAD2439-B917-4126-87BE-16865BAF085D

P2093

Q58762088-A98970A9-EF78-4D21-977C-AD98E3D69E64

Q58762088-AB99F177-7A87-4CA6-9A1B-A3BBA8E8A839

Q58762088-C03C0BEC-44BD-4654-9AF7-1ACB2432DF1B

Q58762088-FAEF6797-1B7F-4022-9CDC-16F5466CD5D9

P2860

Q58762088-028F0A0B-5AA7-4713-AA18-79669C0EA7E1

Q58762088-1759895D-8F67-4239-A300-2BB9ACA025C3

Q58762088-2BD800C2-3ACC-4A42-93CE-DE371DCECCE6

Q58762088-2E98050D-E7E6-482D-8372-632345B490E9

Q58762088-332B2666-E447-4910-BC5F-EF481EBC9772

Q58762088-34378F05-1737-4B8C-8662-A53407ED17E7

Q58762088-454993E7-B4E9-4EA3-A6A0-15CC3074A140

Q58762088-4F1D6405-3839-45D7-B90F-A35DB1E967DF

Q58762088-522B59B3-DFAA-4055-A9BA-A11A31769C4B

Q58762088-57068605-9D15-47B0-96AD-F7A28234D001

P304

Q58762088-63F81BE9-0464-42DC-A895-BC3F73279565

P31

Q58762088-3168666B-44F5-4D6C-B60C-623A77DED57E

P356

Q58762088-1C520AC3-A838-4677-9E12-FC32FA28645B

P407

Q58762088-04EBFF6C-A4A8-4D59-8136-7A95D8B0969D

P433

Q58762088-CFE13DA7-8F02-4988-A4B8-18EC03CF0E6D

P478

Q58762088-9A6F6DFE-8353-49BE-BD11-DB0A53852875

P50

Q58762088-90B19EAB-0B9F-4C1C-BCDE-E7A1835CD8E0

P577

Q58762088-A7A52A8A-F1B1-4A5C-8A75-74A8A86F1772

P698

Q58762088-44AC3CFD-5ABC-44BB-BF63-683DC63B304B

P932

Q58762088-46ABE912-3302-45C6-9698-009FA2D5916C

P356

JOURNAL.PONE.0203453

P1433

P1476

Effects of pharmacist interven ...... esistant Staphylococcus aureus

@en

P2093

Atsushi Komoto

http://www.w3.org/2001/XMLSchema#string

Daisuke Teshima

http://www.w3.org/2001/XMLSchema#string

Takayoshi Maiguma

http://www.w3.org/2001/XMLSchema#string

Tetsuhiro Sugiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

Optimization of time to initial vancomycin target trough improves clinical outcomes

Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia.

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.

Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.

P304

e0203453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0203453

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30188918

http://www.w3.org/2001/XMLSchema#string

P932

6126860

http://www.w3.org/2001/XMLSchema#string